Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180325039148N4Phase 3Completed
Phase 3, randomised, open-label trial in post-dural puncture headache (PDPH) comparing Caffeine, ACTH and Aminophylline (3 arms). Primary endpoints: Headache severity, Patient satisfaction and 1 more. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180325039148N4.